The Single Branch NEXUS™ Clinical Study

NCT03208504 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2023-02-22

No results posted yet for this study

Summary

A prospective, open-label, non-randomized, interventional clinical study, sponsored by Endospan Ltd. Subjects will be followed-up for five years.

Conditions

  • Thoracic Aortic Diseases

Interventions

DEVICE

Nexus™ Aortic Arch Stent graft

surgical implantation of Nexus™ Aortic Arch Stent graft

Sponsors & Collaborators

  • Endospan Ltd.

    lead INDUSTRY

Principal Investigators

  • Jessica Kleine · Endospan Ltd.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-27
Primary Completion
2018-02-16
Completion
2023-01-20

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03208504 on ClinicalTrials.gov